Attorneys Demand Release of NAS Names Amid Purdue Bankruptcy
Attorneys get neonatal abstinence syndrome names to file claims against Purdue.
Sara is a credited freelance writer, editor, contributor, and essayist, as well as a novelist and poet with nearly twenty years of experience. A seasoned publishing professional, she's worked for newspapers, magazines and book publishers in content digitization, editorial, acquisitions and intellectual property. Sara has been an invited speaker at a Careers in Publishing & Authorship event at Michigan State University and a Reading and Writing Instructor at Sylvan Learning Center. She has an MBA degree with a concentration in Marketing and an MA in Clinical Mental Health Counseling, graduating with a 4.2/4.0 GPA. She is also a member of Chi Sigma Iota and a 2020 recipient of the Donald D. Davis scholarship recognizing social responsibility. Sara is certified in children's book writing, HTML coding and social media marketing. Her fifth book, PTSD: Healing from the Inside Out, was released in September 2019 and is available on Amazon. You can find her others books there, too, including Narcissistic Abuse: A Survival Guide, released in December 2017.
Attorneys get neonatal abstinence syndrome names to file claims against Purdue.
Health care provider, Meritus, was able to significantly reduce the number of opioids being prescribed.
Victims on Purdue Pharma’s deceptive marketing practices want justice.
Individuals over 50 who receive a flu shot can reduce their risk of having a heart attack by as much as 85 percent.
A Washington resident started a nonprofit with a mission to save otherwise wasted food.
A physician is arrested after attacking teens who refused to practice social distancing.
Poland will decide whether it will continue to be part of an anti-abuse treaty.
The market for non-opioid pain treatment options is increasing, according to recent data.
Coronavirus patients on ventilators are feeling the pinch of federal drug quotas.
Suboxone film drugmaker settles federal probe finding it misrepresented the drug’s benefits.